search
Back to results

Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy

Primary Purpose

Acute Pain

Status
Unknown status
Phase
Locations
Study Type
Observational
Intervention
Sponsored by
Cure Cancer Worldwide, LLC
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an observational trial for Acute Pain

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient requests to be included in this study

Exclusion Criteria:

  • Patient does not request to be included in this study

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Pain Level Self Assessment
    From enrollment in study to termination of study (August 2020)

    Secondary Outcome Measures

    Full Information

    First Posted
    May 2, 2015
    Last Updated
    May 13, 2015
    Sponsor
    Cure Cancer Worldwide, LLC
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02443675
    Brief Title
    Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
    Official Title
    Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
    Study Type
    Observational

    2. Study Status

    Record Verification Date
    May 2015
    Overall Recruitment Status
    Unknown status
    Study Start Date
    May 2015 (undefined)
    Primary Completion Date
    August 2020 (Anticipated)
    Study Completion Date
    December 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Cure Cancer Worldwide, LLC

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy
    Detailed Description
    Observational Study of Pain Reduction in Late Stage Cancer Patients who are Receiving Low-Dose Chemotherapy (Metabolic Targeting)

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Acute Pain

    7. Study Design

    Enrollment
    300 (Anticipated)
    Primary Outcome Measure Information:
    Title
    Pain Level Self Assessment
    Description
    From enrollment in study to termination of study (August 2020)
    Time Frame
    5 years

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patient requests to be included in this study Exclusion Criteria: Patient does not request to be included in this study
    Study Population Description
    Patients Receiving Low Dose Chemotherapy
    Sampling Method
    Non-Probability Sample
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    gary l smith, mba
    Organizational Affiliation
    Cure Cancer Worldwide, LLC
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Learn more about this trial

    Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy

    We'll reach out to this number within 24 hrs